Lead authored by Dr. A. James Daveson, Gastroen NEW YORK (AP) — Immunic, Inc. IMUX) on Thursday reported a loss of $24.4 million in its third quarter. On a per-share basis, the New York-based ...
Some results have been hidden because they may be inaccessible to you